Integer (NYSE:ITGR – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at Benchmark in a research note issued on Friday, Benzinga reports. They presently have a $130.00 target price on the medical equipment provider’s stock. Benchmark’s price target indicates a potential upside of 19.74% from the stock’s current price. Other analysts […]